Oct 25, 2026 11:52AM
Oct 23, 2026 09:26PM
Oct 23, 2026 04:38PM
Oct 23, 2026 04:37PM
Oct 22, 2026 06:00AM
Oct 21, 2026 06:07AM
Oct 21, 2026 06:05AM Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II / III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
Oct 19, 2026 07:00AM
Oct 5, 2026 07:01AM
Oct 5, 2026 07:00AM
Oct 2, 2026 06:04AM
Oct 2, 2026 02:30AM
Sep 28, 2026 05:33PM
Sep 28, 2026 05:30PM AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics
Sep 22, 2026 06:01AM
Sep 22, 2026 06:00AM
Sep 15, 2026 06:01AM
Sep 15, 2026 06:00AM
Sep 13, 2026 07:47PM
Sep 13, 2026 07:00AM
Aug 25, 2026 06:39PM Akeso's ivonescimab beats durvalumab in biliary tract cancer trial
Aug 25, 2026 06:00PM
Aug 25, 2026 07:02AM
Aug 25, 2026 07:00AM
Aug 12, 2026 09:22AM
Aug 12, 2026 09:22AM
Aug 5, 2026 07:00AM
Jul 23, 2026 04:06PM Summit Therapeutics posts Q2 loss, reports ivonescimab trial data
Jul 23, 2026 04:05PM
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 22, 2026 06:30AM
Jul 22, 2026 06:30AM
Jul 16, 2026 08:00AM
Jul 14, 2026 07:00AM Summit Therapeutics sells antibiotic asset ridinilazole for up to $105M
Jul 14, 2026 07:00AM
Jun 4, 2026 04:30PM
Jun 1, 2026 02:53AM
May 31, 2026 09:06AM
May 30, 2026 08:00AM
Apr 30, 2026 04:32PM
Mar 27, 2026 08:16AM Summit Therapeutics to present ivonescimab data at ELCC 2026
Mar 27, 2026 08:15AM
Feb 26, 2026 06:45PM
Feb 23, 2026 04:05PM
Feb 17, 2026 05:05PM
Jan 30, 2026 04:30PM
Jan 29, 2026 07:30AM
Jan 29, 2026 07:30AM Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Pos
Jan 12, 2026 06:15AM

13,471 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All